CHANG LINDA L 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 8, 2018
Insider Transaction Report
Form 4
CHANG LINDA L
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2018-03-06+10,000→ 30,000 totalExercise: $8.95From: 2019-03-06Exp: 2028-03-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on each of March 06, 2019, March 06, 2020, March 06, 2021 and March 06, 2022, subject to Reporting Person's continued service through the applicable vesting date.